Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioLargo, Inc. (BLGO : OTC)

• Company Description    BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA. Number of Employees: 44

• Price / Volume Information    Yesterday's Closing Price: $0.21 Daily Weekly Monthly 20 Day Moving Average: 341,785 shares Shares Outstanding: 309.21 (millions) Market Capitalization: $66.17 (millions) Beta: 0.11 52 Week High: $0.32 52 Week Low: $0.16 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.24% 14.20% 12 Week 1.90% -7.43% Year To Date 12.63% 8.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 14921 Chestnut St. - Westminster,CA 92683 USA ph: 888-400-2863 fax: 949-625-9819 investorrelations@biolargo.com http://www.biolargo.com

• General Corporate Information    Officers Dennis P. Calvert - Chairman of the Board; Chief Executive Officer and Charles K. Dargan - Chief Financial Officer Joseph L. Provenzano - Executive Vice President; Corporate Secretary and Kenneth R. Code - Chief Science Officer and Director Jack B. Strommen - Director Peer Information BioLargo, Inc. (TURN) BioLargo, Inc. (FWLT) BioLargo, Inc. (CTAK) BioLargo, Inc. (AVNA) BioLargo, Inc. (NLX.) BioLargo, Inc. (T.AGR) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: ENGINRG/R&D SVS Sector: Construction CUSIP: 09065A100 SIC: 2800 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 309.21 Most Recent Split Date: 3.00 (0.04:1) Beta: 0.11 Market Capitalization: $66.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 10.85 Price/Cash Flow: - Price / Sales: 4.71 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -44.62% vs. Previous Quarter: -15.05% ROE 06/30/25 - -67.25 03/31/25 - -54.69 12/31/24 - -41.63 ROA 06/30/25 - -35.58 03/31/25 - -30.42 12/31/24 - -23.61 Current Ratio 06/30/25 - 2.25 03/31/25 - 2.14 12/31/24 - 2.70 Quick Ratio 06/30/25 - 2.14 03/31/25 - 2.03 12/31/24 - 2.57 Operating Margin 06/30/25 - -27.74 03/31/25 - -19.32 12/31/24 - -13.51 Net Margin 06/30/25 - -27.74 03/31/25 - -19.32 12/31/24 - -13.51 Pre-Tax Margin 06/30/25 - -46.93 03/31/25 - -33.72 12/31/24 - -24.45 Book Value 06/30/25 - 0.02 03/31/25 - 0.02 12/31/24 - 0.02 Inventory Turnover 06/30/25 - 22.22 03/31/25 - 33.04 12/31/24 - 39.90 Debt-to-Equity 06/30/25 - 0.25 03/31/25 - 0.23 12/31/24 - 0.15 Debt-to-Capital 06/30/25 - 19.70 03/31/25 - 18.44 12/31/24 - 12.77

Powered by Zacks Investment Research ©